The Global Catheters Market

Home >
Life Sciences >
Medical Devices >
The Global Catheters Market

Report price : $ 4 850
Publication date : August 2007

BCC Research's goal in conducting this study was to determine the present status of the worldwide catheter market and to evaluate its potential over the 5-year period from 2007 to 2012. An assessment of the worldwide catheter market was performed while considering all of its important segments such as cardiovascular, urology, neurovascular, intravenous, and specialty catheters.

INTRODUCTION STUDY GOALS AND OBJECTIVES REASONS FOR DOING THIS STUDY CONTRIBUTIONS TO THE STUDY AND FOR WHOM SCOPE AND FORMAT METHODOLOGY ABOUT THE AUTHOR RELATED BCC REPORTS INFORMATION SOURCES BCC ONLINE SERVICES DISCLAIMER

SUMMARY SUMMARY

Summary Table:

PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2012 ($ BILLIONS/%)

Summary Figure 1:

GLOBAL CATHETER SEGMENT SHARES, 2007 (%)

Summary Figure 2:

PROJECTED GLOBAL CATHETER SHARES BY SEGMENT, 2012 (%)

GLOBAL CATHETER MARKET GLOBAL CATHETER MARKET (CONTINUED) CATHETER APPLICATIONS TYPES OF CATHETERS CARDIOVASCULAR CATHETERS

Table 1 INDICATIONS FOR CARDIAC CATHETERIZATION

Types of Cardiac Catheters

Diagnostic Catheters

Therapeutic Catheters

Angiography Catheters

EP Catheters

Percutaneous Coronary Intervention (PCI) Catheters

Table 2 PTCA PROCEDURES

Rapid Exchange PTCA Balloon Catheters

Over-the-Wire PTCA Catheters

Guiding Catheter

UROLOGY CATHETERS

Urology Catheters (Continued)

Types of Urology Catheters

Intermittent Catheterization

Indwelling Catheterization

Suprapubic Catheterization

Male External Condom Catheters

NEUROVASCULAR CATHETERS

INTRAVENOUS (IV) CATHETERS

Types of IV Catheters

Single Lumen Catheters

Multi-Lumen Catheter

Peripheral Vein Catheter

Central Venous Catheter

Peripherally Inserted Central Catheters

Table 3 COMPLICATIONS DUE TO IV CATHETERS

SPECIALTY CATHETERS

Types of Specialty Catheters

Thermodilution Catheters

Suction Catheters

Oximetry Catheters

END-USER PREFERENCES

SIZE OF CATHETER

MATERIAL USED

COATING

COST

DURATION OF CATHETER IN THE BODY

INFECTION

DEMOGRAPHIC IMPACT

ZERO DIVIDE

Table 4 U.S. RATE OF CARDIOVASCULAR PROCEDURES, 2004*

EUROPEAN DEMOGRAPHICS

Table 5 EUROPEAN CORONARY PROCEDURES, 2004 (PER MILLION POPULATION)

ECONOMIC DEMOGRAPHICS

Table 6 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY, 1960-2003

Table 7 PER CAPITA HEALTHCARE EXPENDITURE BY COUNTRY, 1960-2003 ($)

CATHETER MATERIALS KEY CHARACTERISTICS OF CATHETER MATERIALS

Table 8 CHARACTERISTICS OF CATHETER MATERIALS

CATHETER MATERIALS

LATEX

SILICONE

POLYURETHANE

POLYVINYL CHLORIDE (PVC)

TEFLON (FLUOROPOLYMER)

POLYETHYLENE

CATHETER COATINGS

SILICONE ELASTOMER

HYDROPHILIC COATING

ANTIMICROBIAL COATING

SILVER COATING

ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS

Table 9 ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS

Table 9 (CONTINUED)

Table 10 CATHETER PRODUCTS BY MATERIAL AND COATING TYPE

Table 10 (CONTINUED)

ANALYSIS OF THE GLOBAL CATHETER MARKET

Figure 1 FACTORS INFLUENCING THE MEDICAL DEVICE MARKET

KEY MARKET CHALLENGES

LACK OF CLINICAL DATA DETERS ACCEPTANCE OF NEW PRODUCTS BY MEDICAL STAFF

GROUP PURCHASING IS INDUCING DOWNWARD PRICE PRESSURES

DEVELOPMENTS IN PHARMACOLOGICAL THERAPEUTICS ARE THREATENING USE OF CATHETERS

SOME SEGMENTS ARE HIGHLY CONCENTRATED, IMPACTING THE OVERALL GROWTH OF THE CATHETER MARKET

CATHETER REUSE IS IMPACTING SALES OF DISPOSABLE CATHETERS

KEY MARKET DRIVERS

INCREASE IN PROCEDURES HAS LED TO INCREASED DEMAND FOR CATHETERS

INCREASED DEMAND FOR DISPOSABLE CATHETERS DUE TO RISK OF INFECTION AND AIDS

NEW TECHNOLOGIES IN CATHETERS HAVE INCREASED CATHETER USE

INCREASE IN MINIMALLY INVASIVE PROCEDURES REQUIRING CATHETERS HAS INCREASED SALES

ADVANCES IN IMAGING TECHNOLOGY HAS LED TO NEW APPLICATIONS REQUIRING THE USE OF CATHETERS

KEY MARKET RESTRAINTS

PRICE EROSIONS DUE TO FIERCE COMPETITION ARE SHRINKING REVENUES

LONG FDA APPROVAL TIMES ARE RESULTING IN DELAYED LAUNCHES OF NEW PRODUCTS

REIMBURSEMENT ISSUES HAVE IMPACTED THE USE OF TECHNOLOGICALLY ADVANCED CATHETERS

PHYSICIANS IN THE BUSINESS LONG TERM TEND TO BE RELUCTANT TO ACCEPT NEW DEVICE TECHNOLOGIES

GLOBAL CATHETER MARKET ANALYSIS

REVENUES, SHARES, AND PROJECTIONS BY SEGMENT

Table 11 PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2012 ($ BILLIONS)

Figure 2 PROJECTED GLOBAL CATHETER MARKET, 2005-2012 ($ BILLIONS)

Table 12 PROJECTED GLOBAL CATHETER MARKET SHARES BY SEGMENT, THROUGH 2012 (%)

Figure 3 GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2007 (%)

Figure 4 PROJECTED GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2012 (%)

REVENUES, SHARES, AND PROJECTIONS BY REGION

Table 13 PROJECTED GLOBAL CATHETER MARKET BY REGION, THROUGH 2012 ($ BILLIONS)

Figure 5 PROJECTED GLOBAL CATHETER MARKET BY REGION, 2005-2012 ($ BILLIONS)

Table 14 PROJECTED GLOBAL CATHETER MARKET SHARES BY REGION, 2007 AND 2012 (%)

Figure 6 GLOBAL CATHETER MARKET SHARES BY REGION, 2007 (%)

Figure 7 PROJECTED GLOBAL CATHETER MARKET SHARES BY REGION, 2012 (%)

U.S. Catheter Market

European Catheter Market

Rest of the World Catheter Market

REPROCESSED CATHETERS

REPROCESSED CATHETERS (CONTINUED)

COMPETITIVE STRUCTURE

TYPES OF COMPETITION

TIERS OF COMPETITION

MERGERS AND ACQUISITIONS

Table 15 KEY MERGERS AND ACQUISITIONS WITHIN THE CATHETER MARKET ($)

Table 15 (CONTINUED)

END-USER GROUPS

DISTRIBUTION STRUCTURE

PURCHASE STRUCTURE

COMPETITIVE FACTORS

Regulatory Environment

Pricing

Catheter Properties

Branding

SWOT ANALYSIS OF THE GLOBAL CATHETER MARKET

Figure 8 SWOT ANALYSIS OF THE GLOBAL CATHETER MARKET

STRENGTHS

WEAKNESSES

OPPORTUNITIES

THREATS

CARDIOVASCULAR CATHETERS KEY MARKET CHALLENGES CONTROVERSY REGARDING THE USE OF DRUG ELUTING STENTS (DES) IS AFFECTING CATHETER USE PHARMACOLOGICAL APPROACHES IS THREATENING CATHETER DEMAND LACK OF CLINICAL DATA IS HINDERING ACCEPTANCE OF NEWER CATHETERS BY PHYSICIANS KEY MARKET DRIVERS INCREASE IN THE INCIDENCE OF CV DISEASES IS INCREASING THE NUMBER OF PROCEDURES POPULARITY OF ANGIOPLASTY AND STENTS OVER BYPASS SURGERY IS LEADING TO AN INCREASE IN THE USE OF CARDIAC CATHETERS ANGIOGRAPHY, A NEAR FOOLPROOF METHOD IN THE DETECTION OF CARDIAC DISEASE, IS DRIVING THE INCREASE IN THE NUMBER OF DIAGNOSTIC PROCEDURES INTERVENTIONAL CARDIAC PROCEDURES ARE MORE EFFECTIVE THAN DRUG-BASED THERAPIES KEY MARKET RESTRAINTS CONSTANT PRICE EROSION IS LEADING TO DECREASED REVENUES DECREASE IN RESTENOSIS IS IMPACTING STENT PROCEDURES CATHETER USAGE IS RESTRAINED DUE TO LOW REIMBURSEMENT RATES CARDIOVASCULAR CATHETER MARKET ANALYSIS REVENUES AND PROJECTIONS BY TYPE OF CATHETER

Table 16 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE, THROUGH 2012 ($ BILLIONS)

Figure 9 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE, 2005-2012 ($ BILLIONS)

MARKET SHARES AND PROJECTIONS BY TYPE OF CATHETER

Table 17 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY TYPE, 2007 AND 2012 (%)

MARKET SHARES AND PROJECTIONS BY REGION

Figure 10 GLOBAL CARDIOVASCULAR CATHETER SHARES BY REGION, 2007 (%)

Figure 11 PROJECTED GLOBAL CARDIOVASCULAR CATHETER SHARES BY REGION, 2012 (%)

MARKET SHARES BY COMPANY

Table 18 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY, 2007 (%)

Figure 12 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY, 2007 (%)

CARDIOVASCULAR CATHETER PRODUCTS BY COMPANY

Table 19 ANGIOGRAPHY CATHETER PRODUCTS BY COMPANY

Table 20 EP CATHETER PRODUCTS BY COMPANY

Table 20 (CONTINUED)

Table 21 PTCA CATHETER PRODUCTS BY COMPANY

Table 21 (CONTINUED)

Table 22 GUIDING CATHETER PRODUCTS BY COMPANY

COMPETITIVE STRUCTURE

UROLOGY CATHETER MARKET KEY MARKET CHALLENGES USE OF LONG-TERM CATHETERS IS THREATENING THE GROWTH OF DISPOSABLE CATHETERS USE OF CATHETERSHAS DECLINED DUE TO AN INCREASE IN THE NUMBER OF URINARY TRACT INFECTIONS (UTI) SOME PHYSICIANS ARE NOT READY TO ACCEPT NEW PRODUCTS DUE TO A LACK OF CLINICAL DATA KEY MARKET DRIVERS INCREASE IN UROLOGY PROCEDURES IS LEADING TO INCREASED CATHETER USE CATHETERS WITH ANTIMICROBIAL COATINGS ARE INCREASING CONFIDENCE IN THE USE OF CATHETERS SOME PRODUCTS CAN BE USED BY PATIENTS THEMSELVES, INCREASING PATIENT ADOPTION KEY MARKET RESTRAINTS LENGHTY FDA APPROVAL TIMES HAVE LED TO DELAYS IN THE LAUNCH OF EFFECTIVE ANTIMICROBIAL CATHETERS OCCURRENCES OF UTI IS DISCOURAGING CATHETER USAGE UROLGY CATHETER MARKET ANALYSIS REVENUES AND PROJECTIONS BY TYPE OF CATHETER

Table 23 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, THROUGH 2012 ($ BILLIONS)

Figure 13 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, 2005-2012 ($ MILLIONS)

MARKET SHARES AND PROJECTIONS BY TYPE OF CATHETER

Table 24 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2007 AND 2012 (%)

Figure 14 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2007 (%)

Figure 15 GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2012 (%)

MARKET SHARES BY COMPANY

Table 25 GLOBAL UROLOGY CATHETER MARKET SHARES BY COMPANY, 2007 (%)

Figure 16 UROLOGY CATHETER MARKET SHARES BY COMPANY, 2007 (%)

UROLOGY CATHETER PRODUCTS BY COMPANY

Table 26 UROLOGY CATHETER PRODUCTS BY COMPANY

COMPETITIVE STRUCTURE

NEUROVASCULAR CATHETER MARKET KEY MARKET CHALLENGES COST OF SPECIALIZED MICROCATHETERS IMPACTS THEIR ADOPTION KEY MARKET DRIVERS ADVANCES IN IMAGING TECHNOLOGIES ARE CREATING NEW AREAS OF DIAGNOSIS AND TREATMENT STENTING AND ANEURYSM TREATMENTS ARE INCREASING CATHETER USE NEW CATHETER TECHNOLOGIES ARE IMPROVING PROCEDURESAND INCREASING DEMAND MARKET POTENTIAL EXISTS IN UNMET TREATMENT OPTIONS KEY MARKET RESTRAINTS INCREASED AVAILABILITY OF PHARMACOLOGICAL TREATMENT OPTIONS IS INHIBITING NEURO CATHETER USE SHORTAGE OF PROFESSIONALS QUALIFIED TO PERFORM INVASIVE NEUROLOGICAL PROCEDURES IS IMPACTING NEURO CATHETER SALES MANY PATIENTS DIE BEFORE RECEIVING TREATMENT NEUROVASCULAR CATHETER MARKET ANALYSIS REVENUES AND PROJECTIONS BY SEGMENT

Table 27 PROJECTED GLOBAL NEUROVASCULAR CATHETER MARKET, THROUGH 2012 ($ BILLIONS)

Figure 17 PROJECTED GLOBAL NEUROVASCULAR CATHETER MARKET, 2005-2012 ($ BILLIONS)

MARKET SHARES BY COMPANY

Table 28 GLOBAL NEUROVASCULAR CATHETER MARKET SHARES BY COMPANY, 2007 (%)

Figure 18 GLOBAL NEUROVASCULAR CATHETER MARKET SHARES BY COMPANY, 2007 (%)

NEUROVASCULAR CATHETER PRODUCTS BY COMPANY

Table 29 NEUROVASCULAR CATHETER PRODUCTS BY COMPANY

COMPETITIVE STRUCTURE

INTRAVENOUS CATHETER MARKET KEY MARKET CHALLENGES LACK OF CLINICAL DATA CHALLENGES ADOPTION OF NEW IV CATHETERS MANUFACTURERS FACE PRICE EROSION AND FIERCE COMPETITION KEY MARKET DRIVERS STRICT CATHETER REPLACEMENT RULES ARE INCREASING SALES IV CATHETERS WITH ANTIMICROBIAL COATINGS HAVE IMPROVED THEIR MARKETABILITY INCREASE IN APPLICATIONS AND INTRODUCTION OF NEW TECHNOLOGY IS BOOSTING IV CATHETER SALES KEY MARKET RESTRAINTS CONSTANT PRICE EROSION IS LEADING REVENUE LOSSES REIMBURSEMENT ISSUES REDUCE THE USE OF HIGH-END IV CATHETERS INTRAVENOUS CATHETER MARKET ANALYSIS REVENUES AND PROJECTIONS BY CATHETER TYPE

Table 30 PROJECTED GLOBAL IV CATHETER MARKET BY TYPE, THROUGH 2012 ($ BILLIONS)

Figure 19 PROJECTED GLOBAL INTRAVENOUS CATHETER MARKET, 2005-2012 ($ BILLIONS)

MARKET SHARES AND PROJECTIONS BY CATHETER TYPE

Table 31 PROJECTED GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2007 (%)

Figure 20 GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2007 (%)

Figure 21 PROJECTED GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2012 (%)

MARKET SHARES BY COMPANY

Table 32 GLOBAL INTRAVENOUS CATHETER MARKET SHARES BY COMPANY, 2007 (%)

Figure 22 GLOBAL INTRAVENOUS CATHETER MARKET SHARES BY COMPANY, 2007 (%)

IV CATHETER PRODUCTS BY COMPANY

Peripheral Intravenous Catheter Products by Company

Table 33 PERIPHERAL INTRAVENOUS CATHETER PRODUCTS BY COMPANY

Central Venous Catheter Products by Company

Table 34 CENTRAL VENOUS CATHETER PRODUCTS BY COMPANY

PICC Products by Company

Table 35 PICC PRODUCTS BY COMPANY

COMPETITIVE STRUCTURE

SPECIALTY CATHETERS KEY MARKET CHALLENGES LACK OF CLINICAL DATA IN SUPPORT OF EFFICACY KEY MARKET DRIVERS DEMAND FOR ENHANCED MONITORING DEVICES IS LEADING TO MORE SALES SPECIALTY CATHETER'S EFFECTIVENESS IS FUELING INTEREST IN MEDICAL STAFF AND PROMOTING USE KEY MARKET RESTRAINTS HIGH PRICE OF CATHETERS INHIBITS SALES HIGH COST OF SPECIALTY CATHETERS RENDERS THEM UNAFFORDABLE FOR DEVELOPING COUNTRIES AND REDUCES REVENUES SPECIALTY CATHETER MARKET ANALYSIS REVENUES AND PROJECTIONS BY CATHETER TYPE

Table 36 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, THROUGH 2012 ($ BILLIONS)

Figure 23 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, 2005-2012 ($ BILLIONS)

MARKET SHARES AND PROJECTIONS BY CATHETER TYPE

Table 37 PROJECTED GLOBAL SPECIALTY CATHETER MARKET SHARES BY TYPE, 2007 AND 2012 (%)

Figure 24 GLOBAL SPECIALTY CATHETER SHARES BY TYPE, 2007 (%)

Figure 25 PROJECTED GLOBAL SPECIALTY CATHETER SHARES BY TYPE, 2012 (%)

MARKET SHARES BY COMPANY

Table 38 SPECIALTY CATHETER MARKET SHARES BY COMPANY, 2007 (%)

Figure 26 SPECIALTY CATHETER MARKET SHARES BY COMPANY, 2007 (%)

SPECIALTY PRODUCTS BY COMPANY

Table 39 SPECIALTY CATHETER PRODUCT APPLICATIONS BY COMPANY

COMPETITIVE STRUCTURE

GOVERNMENT REGULATIONS AND ISSUES CATHETER MARKET REGULATIONS CLASS I MEDICAL DEVICES CLASS II CLASS III

Table 40 CATHETER TYPES AND CLASS

Table 40 (CONTINUED)

RECENT 510(K) APPROVALS BY FDA

Table 41 U.S. FDA 510(K) APPROVALS OF CATHETERS, 2006-2007

Table 41 (CONTINUED)

RECENT FDA APPROVALS (2005 TO 2007)

Table 42 RECENT FDA APPROVALS

IBI THERAPY DUAL 8 ABLATION CATHETER AND IBI 1500T6 (USA) GENERATOR

NAVISTAR AND CELSIUS THERMOCOOL IRRIGATED DEFLECTABLE DIAGNOSTIC/ABLATION CATHETER

COAXIA NEUROFLO CATHETER

FDA RECALLS

MISLABELING

NON-STERILE CONDITIONS

MANUFACTURING DEFECTS

MALFUNCTIONS

Table 43 CATHETER RECALLS IN THE PAST YEAR

Table 43 (CONTINUED)

FDA APPROVAL PROCESS

PREMARKET NOTIFICATION 510(K)

Premarket Notification 510(k) (Continued)

PREMARKET APPROVAL

INVESTIGATIONAL DEVICE EXEMPTION (IDE)

ESTABLISHMENT REGISTRATION FORM

MEDICAL DEVICE LISTING

QUALITY SYSTEM (QS) REGULATION

LABELING

MEDICAL DEVICE REPORTING

HEALTHCARE STANDARDS

EUROPEAN STANDARDS

The Active Implantable Medical Device Directive (AIMD) [90/385/EEC]

The Medical Device Directive (MDD) [93/42/EEC]

The In Vitro Medical Devices Directive (IVD) [98/79/EC]

ISO (INTERNATIONAL ORGANIZATION FOR STANDARDS)

Table 44 CATHETER ISO NUMBERS

DIFFERENCES IN EUROPEAN AND U.S. REGULATIONS

COMPANY PROFILES ABBOTT LABORATORIES

Table 45 ABBOTT LABORATORIES' CATHETER PRODUCTS

Table 45 (CONTINUED)

ARROW INTERNATIONAL

Table 46 ARROW INTERNATIONAL CATHETER PRODUCTS

ASTRA TECH AB

Table 47 ASTRA TECH CATHETER PRODUCTS

B BRAUN MELSUNGEN AG

Table 48 B BRAUN CATHETER PRODUCTS

BECTON, DICKINSON & CO.

Table 49 BD CATHETER PRODUCTS

BOSTON SCIENTIFIC

Table 50 BOSTON SCIENTIFIC CATHETER PRODUCTS

CARDINAL HEALTH

Table 51 CARDINAL HEALTH CATHETER PRODUCTS

COLOPLAST GROUP

Table 52 COLOPLAST CATHETER PRODUCTS

COOK MEDICAL

Table 53 COOK MEDICAL CATHETER PRODUCTS

CR BARD

Table 54 CR BARD CATHETER PRODUCTS

Table 54 (CONTINUED)

EDWARDS LIFESCIENCES

Table 55 EDWARDS LIFESCIENCES CATHETER PRODUCTS

HOSPIRA, INC.

Table 56 HOSPIRA CATHETER PRODUCTS

IRVINE BIOMEDICAL, INC.

Table 57 IRVINE BIOMEDICAL CATHETER PRODUCTS

JOHNSON & JOHNSON

Table 58 JOHNSON & JOHNSON CATHETER PRODUCTS

MEDTRONIC, INC.

Table 59 MEDTRONIC CATHETER PRODUCTS

ROCHESTER MEDICAL

Table 60 ROCHESTER MEDICAL CATHETER PRODUCTS

SMITHS MEDICAL

Table 61 SMITHS MEDICAL CATHETER PRODUCTS

Table 61 (CONTINUED)

ST. JUDE MEDICAL

Table 62 ST. JUDE MEDICAL CATHETER PRODUCTS

TERUMO MEDICAL CORP.

Table 63 TERUMO CORP. CATHETER PRODUCTS

Table 63 (CONTINUED)

Table 64 REVENUES OF KEY CATHETER MANUFACTURERS, 2005 AND 2006 ($ BILLIONS)

Table 64 (CONTINUED)

PATENT ANALYSIS PATENT ANALYSIS BY SEGMENT

Table 65 CATHETER PATENT SHARES BY SEGMENT, 2002 TO MAY 2007 (%)

Figure 27 CATHETER PATENT SHARES BY SEGMENT, 2002 TO MAY 2007 (%)

CARDIOVASCULAR CATHETER PATENTS

Table 66 CARDIOVASCULAR CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY

Figure 28 CARDIOVASCULAR PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)

UROLOGY CATHETER PATENTS

Table 67 UROLOGY CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)

Figure 29 UROLOGY CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)

IV CATHETER PATENTS

Table 68 IV CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)

Figure 30 IV CATHETER PATENT ACTIVITY, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)

SPECIALTY CATHETER PATENTS

Table 69 SPECIALTY CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)

Figure 31 SPECIALTY CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)

CATHETER PATENT ACTIVITY BY ASSIGNEE

Table 70 CATHETER PATENT ACTIVITY BY ASSIGNEE, 2002 TO MAY 2007 (NUMBER OF PATENTS)

Figure 32 CATHETER PATENT SHARES BY ASSIGNEE, 2002 TO MAY 2007 (%)

Figure 32 (CONTINUED)

Table 71 U.S. CATHETER PATENT NUMBERS BY ASSIGNEE, 1995 TO MAY

Table 71 (CONTINUED)

CATHETER PATENT ACTIVITY BY COUNTRY

Table 72 CATHETER PATENT ACTIVITY BY COUNTRY, 2002 TO MAY

Figure 33 CATHETER PATENT SHARES BY COUNTRY, 2002 TO MAY 2007 (%)

CATHETER PATENT ACTIVITY BY YEAR

Table 73 PATENT FILINGS PER YEAR, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)

Figure 34 PATENT FILINGS PER YEAR, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)

U.S. PATENT ABSTRACTS

OCCLUSION BALLOON CATHETER WITH LONGITUDINALLY EXPANDABLE BALLOON

CATHETER-ADVANCEMENT ACTUATED NEEDLE RETRACTION SYSTEM

STEERABLE CATHETER

MULTI-LUMEN CATHETER HAVING A SOFT TIP

CATHETER FOR ELECTROPHYSIOLOGY

CATHETER WITH A DISPOSABLE BALLOON

CURVED ABLATION CATHETER FOR ENHANCED MANEUVERING

EXTERNAL URINARY CATHETER

MICROCATHETER FOR RETRIEVING EMBOLIC COILS

INTRAVENOUS CATHETER

HIGH TORQUE BALLOON CATHETER

SURGICAL CATHETER WITH AUXILIARY LUMEN

CONCLUSIONS OF THE PATENT ANALYSIS

APPENDIX

Table 74 CATHETER DEFINITIONS

Table 74 (CONTINUED)

Table 75 KEY INDUSTRY WEBSITES

Table 76 KEY REGULATORY AND INFORMATION WEBSITES

CURRENCY CONVERSIONS

LIST OF TABLES

Summary Table:

PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2012 ($ BILLIONS/%)

Table 1 INDICATIONS FOR CARDIAC CATHETERIZATION

Table 2 PTCA PROCEDURES

Table 3 COMPLICATIONS DUE TO IV CATHETERS

Table 4 U.S. RATE OF CARDIOVASCULAR PROCEDURES, 2004*

Table 5 EUROPEAN CORONARY PROCEDURES, 2004 (PER MILLION POPULATION)

Table 6 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY, 1960-